Skip to main content

Table 1 Pharmacokinetic parameters of HB-002.1

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

AUC (g · days/ml) MRT (hr) T1/2(hr) Cmax(μg/ml)
81.46 180 120 20.27
  1. Note: AUC, area under the curve concentration; MRT, mean.
  2. residence time; T1/2, half-life; Cmax: maximal concentration.
\